Status: current, Defined. Date: 31-Jan 2016. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3299298010 | Oral form nevirapine (product) | en | Fully specified name | Inactive | Initial character case insensitive | SNOMED CT core |
| 3299525017 | Oral form nevirapine | en | Synonym | Inactive | Initial character case insensitive | SNOMED CT core |
| 3488608017 | Product containing nevirapine in oral dosage form (medicinal product form) | en | Fully specified name | Inactive | Case insensitive | SNOMED CT core |
| 3497700016 | Product containing nevirapine in oral dosage form | en | Synonym | Inactive | Case insensitive | SNOMED CT core |
| 3497701017 | Nevirapine in oral dosage form | en | Synonym | Inactive | Case insensitive | SNOMED CT core |
| 3711001015 | Product containing nevirapine in oral dose form (medicinal product form) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
| 3711002010 | Nevirapine-containing product in oral dose form | en | Synonym | Active | Case insensitive | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Nevirapine-containing product in oral dose form | Plays role | Antiretroviral therapeutic role | true | Inferred relationship | Some | ||
| Nevirapine-containing product in oral dose form | Is a | Nevirapine-containing product | true | Inferred relationship | Some | ||
| Nevirapine-containing product in oral dose form | Is a | Product manufactured as oral dose form | true | Inferred relationship | Some | ||
| Nevirapine-containing product in oral dose form | Has active ingredient | Nevirapine | true | Inferred relationship | Some | 1 | |
| Nevirapine-containing product in oral dose form | Has manufactured dose form | Oral dose form | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Nevirapine only product in oral dose form | Is a | True | Nevirapine-containing product in oral dose form | Inferred relationship | Some | |
| Nevirapine 200 mg oral tablet | Is a | False | Nevirapine-containing product in oral dose form | Inferred relationship | Some | |
| Nevirapine (as nevirapine hemihydrate) 10 mg/mL oral suspension | Is a | False | Nevirapine-containing product in oral dose form | Inferred relationship | Some | |
| Nevirapine 400 mg prolonged-release oral tablet | Is a | False | Nevirapine-containing product in oral dose form | Inferred relationship | Some | |
| Lamivudine- and nevirapine- and stavudine-containing product in oral dose form | Is a | True | Nevirapine-containing product in oral dose form | Inferred relationship | Some | |
| Lamivudine- and nevirapine- and zidovudine-containing product in oral dose form | Is a | True | Nevirapine-containing product in oral dose form | Inferred relationship | Some |
This concept is not in any reference sets
FHIR